From July 1, 2022 to September 30, 2022, the company has repurchased 16,117,100 shares, representing 0.86% for CNY 183.6 million. With this, the company has completed the repurchase of 36,138,098 shares, representing 1.94% for CNY 425.67 million under the buyback announced on April 26, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.21 CNY | +1.61% | -3.41% | +17.12% |
Apr. 29 | Jointown Pharma's Q1 Profit, Revenue Fall 4% | MT |
Apr. 29 | Jointown Pharmaceutical Group's 2023 Profit Jumps 4% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.12% | 4.32B | |
+14.53% | 69.79B | |
+7.11% | 8.2B | |
-20.55% | 7.96B | |
-5.04% | 7.91B | |
+2.32% | 4.69B | |
-1.24% | 3.99B | |
-3.78% | 3.81B | |
+21.42% | 3.62B | |
+8.64% | 3.32B |
- Stock Market
- Equities
- 600998 Stock
- News Jointown Pharmaceutical Group Co., Ltd
- Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.